Tobacco Documents Online

.+ . I ., , f, hW` 0 0 0; 0 2 4 rr~I - .1, . lns9 LLS° %L5 National Cancer Institute Bethesda, Maryland 20014 Pat Newman 301-496-7915 NATIONAL CANCER ADVISORY BOARD SUBCOMMITTEES For release in A.M. Papers Tuesday, April 17, 1973 BEW's National Cancer Institute today announced the membership of two ad hoc subcommittees to review research programs conducted under the National Cancer Program. One subcommittee is reviewing overall research of the NCI Special Virus Cancer Program and make recommendations for future virus-cancer research. The other subcommittee is reviewing a research program conducted by Litton Bionetics, Inc., at the Frederick Cancer Research Center, Fort Detrick, Frederick, Maryland. Litton's program performance will be examined and recommendations made for further development of an advanced systems laboratory at Frederick. This will scrve as a sophisticated resource for experiments by visiting U.S. and foreign scientists. Subcommittee members were selected by the National Cancer Advisory Board, a group of 23 cancer experts appointed last year by President Nixon. The Board advises and assists the Director of the National Cancer Institute in administering the National Cancer Program. (more) U S Dr.PARTTMI:";T OF Hf 1l TI7, I^11c'ATlnr;, l.NI1 C. ~LFqI,E FIdMonal InSl1tulibuf Hi•nIlh

- 2 - h hicuuu;'0 2 5 Members of the Ad Hoc Advisory Subcommittee for the Special Virus Cancer Program are: I Norton D. Zinder, Ph. D. , Chairman Professor of Molecular Genetics Rockefeller University New York, New York James E. Darnell, M.D. Chairman, Department of Biological Sciences Columbia University New York, New York Vittorio Defendi, M.D. Senior Member of Wistar Institute Wistar Professor of Pathology at the University of Pennsylvania School of Medicine Wistar Institute Philadelphia, Pennsylvania Robert A. Good, M.D., Ph.D. President and Director Sloan-Kettering Institute for Cancer Researrh New York, New York Aaron J. Shatkin, Ph.D. Full Member, Department of Cell Biology Roche Institute of Molecular Biology Nutley, New Jersey Chandler A. Stetson, M.D. Dean, Medical School University of Florida Gainesville, Florida Richard A. %je1_ma, D.V.M. Special Assistant for Program Planning and Evaluation NIH National Institute of Environmental Health Sciences Research Triangle Park, North Carolina Maurice Guss, Ph.D. Executive Secretary Developmental Research Segment Special Virus Cancer Program NIH National Cancer Institute Bethesda, Maryland Keith R. Porter, Ph.D. Professor and Chairman Department of Molecular, Cellular and Developmental Biology University of Colorado Boulder, Colorado James M. Price, M.D., Ph.D. Vice President, Corporate Research and Experimental Therapy Abbott Laboratories North Chicago, Illinois Wallace P. Rowe, M.D. Chief, Laboratory of Viral Diseases NIH National Institute of Allergy and Infectious Diseases Bethesda, Maryland (more)

hhiLOUU/U26 3 Members of the Ad Hoc Advisory Subcommittee for the Frederick Cancer Research Center are: Sidney Weinhouse, Ph.D., Chairman Director, Fels Research Institute Temple University Health Sciences Center School of Medicine Philadelphia, Pennsylvania *Harold Amos, Ph.D. Professor, Dept. of Microbiology and Molecular Genetics Harvard Medical School Boston, Massachusetts James Liverman, Ph.D., Director Division of B iomedical and Environmenta7. Research Atomic Energy Commission Washington, D. C. Joseph S. Pagano, M.D. Director, Div ision of Infectious Diseases Dept. of Medi cine and Bacteriology University of North Carolina School of Med icine Chapel Hill, North Carolina John J. Burns, Ph.D. Vice President for Research Hoffmann-La Roche Inc. Nutley, New Jersey Britton Chance, Ph.D. Professor of Biophysics and Biochemistry School of Medicine University of Pennsylvania Philadelphia, Pennsylvania *Frank J. Dixon, M.D. Chairman, Biomedical Research Department Scripps Clinic and Research Foundation La Jolla, California Maurice Green, Ph.D. Professor and Director Institute for Molecular Virology St. Louis University School of Medicine St. Louis, Missouri William W. Payne, Sc.D. Scientific Coordinator NCI Frederick Cancer Research Center Fort Detrick, Frederick, Maryland *Herold P. Rusch, M.D. Director, McA rdle Laboratory for Cancer Research University of Wisconsin Medical Center Madison, Wisconsin *Sol Spiegelman, Ph.D. Director, Institute of Cancer Research College of Physicians and SurgEons Columbia University New York, New York Robert E. Ste•.•enson, Ph.D. (Ex Officio) General Manage r Litton Bionetics, Inc. NCI Frederick Cancer Research Center Fort Detrick, Frederick, Maryland *Members of National Cancer Advisory Board N lf It